MedPath

Camino Pharma, LLC

Camino Pharma, LLC logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A First-in-Human Study of SBP-9330 in Healthy Subjects

Phase 1
Completed
Conditions
Smoking Cessation
Interventions
Drug: Placebo
First Posted Date
2021-07-02
Last Posted Date
2024-04-16
Lead Sponsor
Camino Pharma, LLC
Target Recruit Count
90
Registration Number
NCT04948827
Locations
🇺🇸

Altasciences Clinical Kansas, Inc, Overland Park, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath